Co-precipitation with PVP and Agar to Improve Physicomechanical Properties of Ibuprofen

Document Type: Original Article

Authors

Drug applied Research Centre and School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

Keywords


P. Crystal engineering and particle design for the powder

compaction process. Drug Dev Ind Pharm 1992; 18:677-721.

2. York P, Shekunov Byu. Crystallization processes in pharmaceutical technology and drug delivery design. J Cryst Growth 2000; 211:122-136.

 

3. Rasenack N, Muller B. Crystal habit and tableting behavior of ibuprofen. Int J Pharm 2002a; 244:45–57.

 

4. Rasenack N, Muller B. Ibuprofen crystal with optimized properties. Int J Pharm 2002b; 245: 9–24.

 

5. Khan MA, Bolton S, Kislalioglu MS. Optimization of process variables for the preparation of Ibuprofenco-precipitates with Eudragit S100. Int J Pharm 1994; 102:185-192.

 

6. Kachrimanis K, Ktistis G, Malamataris S. Crystallization conditions and physicochemical properties of ibuprofen- Eudragit S100 spherical crystal agglomerates prepared by the solvent-change technique. Int J Pharm 1998; 173:61-74.

 

7. Pawar A, Paradkar A, Kadam Sh, Mahadik K. Agglomeration of Ibuprofenwith Talc by Novel Crystallo-Co-Agglomeration Technique. AAPS PharmSciTech 2004; 7;5:e55 .

 

8. Zimmermann A, Millqvist-Fureby A, Ringkjbing Elema M, Hansen T, Müllertz A, Hovgaard L. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: Effects on physicochemical properties. Eur J Pharm Biopharm 2009; 71:109–116.

 

9. Li XS, Wang JX, Shen ZG, Zhang PY, Chen JF, Yun J. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method. Int J Pharm 2007; 342:26–32.

 

10. Carr RL. Classifying flow properties of solids. Chem Eng 1965; 72:69–72.

 

11. Carr RL. Evaluation flow properties of solids. Chem Eng 1965; 72:163–168.

 

12. Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instr 1965; 4:117–212.

 

13. Brown S, Rowley G, Pearson JT. Surface treatment of the hydrophobic drug danazol to improve drug dissolution. Int J Pharm.1998; 165: 227–237.

 

14. Fell JT, Newton JM. Determination of tablet strength by the diametral– compression test. J Pharm Sci 1970; 59:688–691.

 

15. Tian F, Saville DJ, Gordon KC, Strachan CJ, Zeitler JA, Sandler N,

 

 

et al

. The influence of various excipients on the conversion kinetics of carbamazepine polymorphs in aqueous suspension. J Pharm Pharmacol 2007; 59:193–201.

16. Lu GW, Smith M, Geiger BM, Pfund W. Characterization of a novel polymorphic form of celecoxib. J Pharm Sci 2006; 95:305-317.

 

17. Raghavan L, Davis AF, Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 2001; 212:213-221.

 

18. Jain P, Banga AK. Inhibition of crystallization in drug-in-adhesive-type transdermal patches. Int J Pharm 2010; 394:68-74.

 

19. Subedi RK, Ryoob JP, Moon Ch, Choi HK. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan. Int J Pharm 2011; 419:209– 214.

 

20. Yang J, Grey K, Doney J. An improved kinetics approach to describe the physical stability of amorphous solid dispersions Original Research Article. Inter J Pharm 2010; 384: 24-31.

 

21. Jbiilou M, Ettabia A, Guyot-Harmann AM, Guyot JC. Ibuprofenagglomerates preparation by phase separation. Drug Dev Ind J Pharm 1999; 25:297-305.

 

22. Tiwary AK. Modification of crystal habit and its role in dosage form performance. Drug Dev Ind Pharm 2001; 27:699-709.

 

23. Garekani HA, Sadeghi F, Badiee A, Mostafa SA, Rajabi-Siahboomi AR. Crystal Habit Modifications of Ibuprofen and their Physicomechanical Characteristics. Drug Dev Ind Pharm 2001; 27:803–809.

 

24. El-Said Y. Effect of Co-solvents on water content and physical properties of acetaminophen crystallized from aqueous solutions. STP Pharm Sci 1995; 5:232-237.

 

25. Garekani HA, Ford JL, Rubinstein MH, Rajabi- Siahboomi AR. Highly compressible paracetamol. I: Crystallization and characterization. Int J Pharm 2000; 208:87-99.

 

26. Joiris E, Di Martino P, Berneron C, Guyot-Hermann AM, Guyot JC. Compression behavior of orthorhombic paracetamol. Pharm Res 1998; 15:1122–1130.

 

27. Milosovitch G. Direct compression of tablets. Drug Cosmet Ind 1963; 5:557-569.

 

28. Nystrom C, Mazur J, Sjogren J. Studies on direct compression of tablets II. The influence of the particle size of a dry binder on the mechanical strength of tablets. Int J Pharm 1982; 10:209–218.

 

29. Duberg M, Nystrom C. Studies on direct compression of tablets XII. The consolidation and bonding properties of some pharmaceutical compounds and their mixtures with Avicel 105. Int J Pharm Tech Prod Manuf 1985; 6:17–25.

 

30. Nystrom C, Glazer M. Studies on direct compression of tablets. XIII. The effect of some dry binders on the tablet strength of compounds with different fragmentation propensity. Int J Pharm 1985; 23:255–263.

 

31. Abdel-Hamid S, Alshihabi F, Betz G. Investigating the effect of particle size and shape on high speed tableting through radial die-wall pressure monitoring. Int J Pharm 2011; 413:29-35.

 

32. Podczeck F, Al-Muti E. The tensile strength of bilayered tablets made from different grades of microcrystalline cellulose. Eur J Pharm Sci 2010; 41:483-488.

 

33. Paluch KJ, Tajber L, Adamczyk B, Corrigan OI, Healy AM. A novel approach to crystallisation of nanodispersible microparticles by spray drying for improved tabletability. Int J Pharm 2012; 436:873-876.

 

34. Nokhodchi A, Rubinstein MH, Larhrib H, Guyot JC. The effect of moisture content on the energies involved in the compaction of ibuprofen. Int J Pharm 1995; 120:13–20.

 

35. Roberts M, Ford JL, MacLeod GS, Fell JT, Smith GW,

 

 

et al

. Effect of punch tip geometry and embossment on the punch tip adherence of a model Ibuprofenformulation. J Pharm Pharmacol 2004; 56: 947–950.

36. Ye F, Yaghmur A, Jensen H, Larsen SW, Larsen C, Østergaard J. Real-time UV imaging of drug diffusion and release from Pluronic F127 hydrogels .Eur J Pharm Sci 2011; 43:236-243.

 

37. Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm 2002; 231:131-144.

 

38. Smiti K, Garima C, Arvind KB. Role of additives like polymers and surfactants in the crystaliization of Mebendazol. Yakugaku Zasshi 2008; 128:281-289.